| Tutorial | Discussion | New page feed | Reviewers | Curation tool Suggestions | Coordination |
 | 22 unreviewed articles as of 23 August 2025
|
| Created | Article | Extract | Class | Creator (# edits) | Notes |
|---|---|---|---|---|---|
| 2024-11-10 | Qing-Yun Chen (Chinese chemist (1929-2023)) | Qing-Yun Chen (Chinese: 陈庆云; pinyin: Chén Qìngyún; 25 January 1929 – 2 March 2023) was a Chinese organic chemist and member of the Chinese Academy of Sciences, specializing in the field of organic fluorine chemistry. | Start | Tokisaki Kurumi (8359) | |
| 2025-07-16 | IHCH-8134 (Chemical compound) | IHCH-8134 is a drug of the oxazinopyridoindole family which acts as an agonist at the 5-HT2A serotonin receptor. It was derived by structural simplification of the 5-HT2A antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7079, which was found to be a non-hallucinogenic biased 5-HT2A agonist that was active in antidepressant assays but did not produce psychedelic-like responding in mice. | Stub | BaeyerDrewson (646) | |
| 2025-07-17 | 177 Lu-NNS309 (Investigational radiopharmaceutical compound) | 177Lu-NNS309 is an investigational radiopharmaceutical compound currently under development by Novartis Pharmaceuticals for the treatment of various solid tumors. The compound is being evaluated in Phase I clinical trials for patients with pancreatic, lung, breast, and colorectal cancers. | C | Noxoug1 (5697) | |
| 2025-08-08 | Sozinibercept (Pharmaceutical compound) | Sozinibercept was an investigational drug intended to be used to treat certain eye conditions such as wet age-related macular degeneration (AMD). It is administered intravitreally in combination with other Anti-VEGF-A including aflibercept, faricimab, ranibizumab, and bevacizumab. | Start | Mahmoudalrawi (2571) | |
| 2025-07-29 | OpRegen (Allogeneic cell therapy) | OpRegen (also known as RG6501) is an investigational allogeneic cell therapy developed by Lineage Cell Therapeutics for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The therapy consists of human retinal pigment epithelial (RPE) cells administered via subretinal injection as a single treatment. | C | Noxoug1 (5697) | |
| 2025-07-31 | Vatinoxan (Pharmaceutical compound) | Vatinoxan, originally known as MK-467, is an α2-adrenergic receptor antagonist used in veterinary medicine alongside α2-adrenergic receptor agonists to counteract vasoconstriction and hypertension while maintaining sedation. Vatinoxan does not cross the blood–brain barrier giving it a unique pharmacological profile compared to the other α2-adrenergic receptor antagonists and distinct clinical application. | C | Sacristy (493) | |
| 2025-08-13 | Structural Dynamics Response Assay (Biochemical analysis procedure) | The structural dynamics response (SDR) assay is a type of biophysical test used to measure ligand binding to a target protein. The assay is configured as a simple mix and read format that can be conducted in very low volumes, therefore suitable for drug discovery applications such as high throughput screening (HTS), or in the development of a drug candidate during medicinal chemistry optimization cycles. | Start | Hoffmacs (374) | |
| 2025-08-12 | Erbium(III) sulfate (Chemical compound) | Erbium(III) sulfate is an erbium compound with the chemical formula Er2(SO4)3. It is a pink crystalline salt, readily absorbing water to form an octahydrate. It is used as a colorant in glass manufacturing and porcelain enamel glazes, as well as a dopant in the production of optical fiber. | Stub | Slavxe (506) | |
| 2025-01-19 | Fluorescence upconversion (Ultrafast laser spectroscopic technique) | Fluorescence upconversion (FU) is an ultrafast laser spectroscopic technique. It is a variant of sum-frequency generation (of which the second-harmonic generation (SHG) is a special case) but applied to the detection of the incoherent fluorescence. It is therefore closely related to the Optical Kerr Gating (OKG) technique. | C | Ozzwah (104) | |
| 2025-06-16 | Sefaxersen (Antisense oligonucleotide therapy under development) | Sefaxersen (also known as RO7434656, RG6299, ISIS-696844 and IONIS-FB-LRx) is an investigational antisense oligonucleotide (ASO) drug developed by Roche Holding AG in partnership with Ionis Pharmaceuticals. It targets complement factor B (CFB) to treat complement system-mediated diseases, primarily IgA nephropathy (IgAN) and geographic atrophy (GA) secondary to age-related macular degeneration. | C | Noxoug1 (5697) | |
| 2025-08-11 | Plutonium(III) phosphate (Chemical compound) | Plutonium(III) phosphate is an inorganic compound of plutonium, with the molecular formula PuPO4. It is the trivalent plutonium salt of phosphoric acid. | Start | Laura240406 (4129) | |
| 2025-08-15 | Erbium(III) carbonate (Chemical compound) | Erbium(III) carbonate is an erbium compound with the chemical formula Er2(CO3)3. | Start | Laura240406 (4129) | |
| 2025-08-18 | Jens Bruun de Neergaard (Danish judge and landowner) | Jens Bruun de Neergaard (14 June 1742 – 22 April 1788) was a Danish judge and landowner. He owned Svenstrup Manor, at Broup, Køge Municipality, whouse present main building he constructed in the 1780s. On 31 May 1780, alongside his younger brother, Johan Thomas de Neergaard (1745–1806), he was ennobled by letters patent. | Start | Ramblersen2 (87679) | |
| 2025-05-31 | Musahaqah | Musaheqeh (Arabic: مساحقه) is a legal and religious term. In Islamic jurisprudence (fiqh) and under the Islamic Penal Code of Iran, musaheqeh refers to a situation in which an adult, mentally competent, and consenting woman brings her genitalia into contact with the genitalia of another woman. | Stub | JesusisGreat7 (2692) | |
| 2025-08-04 | Hellenic Championship (Tennis) (Tennis tournament) | The Hellenic Championship is an ATP 250 tournament held in Athens, Greece. The event is played on indoor hardcourt at the OAKA Basketball Arena, a multi-purpose venue that was used for the 2004 Summer Olympics. It replaces the Belgrade Open on the calendar and it is scheduled to debut in November 2025. | Stub | Haddad Maia fan (3971) | |
| 2025-08-22 | Optimized Multicolor Immunofluorescence Panel | Optimized Multicolor Immunofluorescence Panel, abbreviation OMIP, was a series of standardized multi-color flow cytometry panel launched by International Society for Advancement of Cytometry (ISAC), published in the form of columns in Cytometry Part A. | Start | Htmlzycq (4852) | |
| 2025-08-21 | Selnoflast (Experimental NLRP3 inflammasome inhibitor for neurological conditions) | Selnoflast (development codes RO7486967, RG-6418, IZD334) is an experimental small-molecule drug developed by Hoffmann-La Roche for the treatment of neuroinflammatory conditions. It is an orally active, selective, and reversible inhibitor of the NLRP3 inflammasome, a key component of the innate immune system involved in inflammatory responses. | C | Noxoug1 (5697) | |
| 2005-05-21 | Antineoplastic (Class of drugs used to treat malignant tumors) | Antineoplastic agents, also known as anticancer drugs or antineoplastic drugs, are medications used to treat malignant tumors. These drugs work through various mechanisms to kill or inhibit cancer cells to achieve the goal of treating malignant tumors. | FA | 63.193.126.34 | |
| 2025-08-22 | Zimei Bu | Zimei Bu, PhD is a protein chemist in the City College of New York, where she is Professor of Chemistry and Biochemistry and Laboratory Director. | Start | Wang Walton (21) | |
| 2025-08-14 | Lariocidin (Chemical compound) | Lariocidin (abbreviated as LAR) is a naturally occurring lasso-shaped peptide antibiotic produced by soil-derived bacterium Paenibacillus sp. M2. It is the first lasso peptide reported to inhibit protein synthesis in bacteria through interactions with the ribosome. | C | TravinD (11) | |
| 2025-08-22 | Rilzabrutinib | Rilzabrutinib is an oral, reversible covalent inhibitor of Bruton's tyrosine kinase, may increase platelet counts in patients with immune thrombocytopenia by means of dual mechanisms of action: decreased macrophage (Fcγ receptor)–mediated platelet destruction and reduced production of pathogenic autoantibodies. | Stub | Kelu (290) | |
| 2025-05-04 | Erythrocyte-based drug delivery (Drug delivery method) | Erythrocyte-based drug delivery systems (EBDDS) use red blood cells, their membranes, or their components to release and deliver pharmaceutical agents throughout the body in a controlled manner. Because red blood cells circulate for long periods of time and are potentially non-immunogenic, they are an attractive vector for drug delivery via the circulatory system. | C | DrugDelivery2025 (6) |
Last updated by SDZeroBot operator / talk at 01:43, 23 August 2025 (UTC)